ArticleJournal of breast cancer2020

Clinical Impact of Primary Prophylactic Pegfilgrastim in Breast Cancer Patients Receiving Adjuvant Docetaxel-Doxorubicin-Cyclophosphamide Chemotherapy.

Ye Won Jeon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.